Sequential Induction of Effector Function, Tissue Migration and Cell Death during Polyclonal Activation of Mouse Regulatory T-Cells

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Langenhorst, Daniela ^a   Gogishvili, Tea ^a   Ribechini, Eliana ^a   Kneitz, Susanne ^a   McPherson, Kirsty ^a,b   Lutz, Manfred B ^a   Hünig, Thomas ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BIOTINYLATION; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; IMMUNE RESPONSE; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN INDUCTION; PROTEIN PURIFICATION; PROTEIN SECRETION; REGULATORY T LYMPHOCYTE; UPREGULATION;

ANIMALS; ANTIBODIES; ANTIGENS, CD28; APOPTOSIS; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; CLONE CELLS; GENE EXPRESSION; INFLAMMATION; INTERLEUKIN-10; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; RECEPTORS, CCR5; RECEPTORS, CCR7; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY;

MUS;

EID: 84870589141     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050080     Document Type: Article

References (44)

1. Sakaguchi S, (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6: 345-352.
2. Tang Q, Bluestone JA, (2008) The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 9: 239-244.
3. Barthlott T, Moncrieffe H, Veldhoen M, Atkins CJ, Christensen J, et al. (2005) CD25+ CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production. Int Immunol 17: 279-288.
4. de la Rosa M, Rutz S, Dorninger H, Scheffold A, (2004) Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur J Immunol 34: 2480-2488.
5. Papiernik M, de Moraes ML, Pontoux C, Vasseur F, Penit C, (1998) Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 10: 371-378.
6. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W, (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274.
7. Maynard CL, Harrington LE, Janowski KM, Oliver JR, Zindl CL, et al. (2007) Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat Immunol 8: 931-941.
8. Thornton AM, Shevach EM, (1998) CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188: 287-296.
9. Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, et al. (2008) Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28: 546-558.
10. Siegmund K, Feuerer M, Siewert C, Ghani S, Haubold U, et al. (2005) Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 106: 3097-3104.
11. Huehn J, Hamann A, (2005) Homing to suppress: address codes for Treg migration. Trends Immunol 26: 632-636.
12. Huehn J, Siegmund K, Lehmann JC, Siewert C, Haubold U, et al. (2004) Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J Exp Med 199: 303-313.
13. Zhang N, Schroppel B, Lal G, Jakubzick C, Mao X, et al. (2009) Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity 30: 458-469.
14. Pandiyan P, Lenardo MJ, (2008) The control of CD4+CD25+Foxp3+ regulatory T cell survival. Biol Direct 3: 6.
15. Gogishvili T, Lühder F, Goebbels S, Beer-Hammer S, Pfeffer K, et al. (2012) Cell-intrinsic and-extrinsic control of Treg-cell homeostasis and function revealed by induced CD28 deletion. Eur J Immunol doi: 10.1002/eji.201242824.
16. Knoechel B, Lohr J, Kahn E, Bluestone JA, Abbas AK, (2005) Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen. J Exp Med 202: 1375-1386.
17. Beyersdorf N, Gaupp S, Balbach K, Schmidt J, Toyka KV, et al. (2005) Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis. J Exp Med 202: 445-455.
18. Lin CH, Hünig T, (2003) Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist. Eur J Immunol 33: 626-638.
19. Gogishvili T, Langenhorst D, Lühder F, Elias F, Elflein K, et al. (2009) Rapid regulatory T-cell response prevents cytokine storm in CD28 superagonist treated mice. PLoS One 4: e4643.
20. Guilliams M, Bosschaerts T, Herin M, Hünig T, Loi P, et al. (2008) Experimental expansion of the regulatory T cell population increases resistance to African trypanosomiasis. J Infect Dis 198: 781-791.
21. Zaiss MM, Frey B, Hess A, Zwerina J, Luther J, et al. (2010) Regulatory T cells protect from local and systemic bone destruction in arthritis. J Immunol 184: 7238-7246.
22. Hünig T, (2007) Manipulation of regulatory T-cell number and function with CD28-specific monoclonal antibodies. Adv Immunol 95: 111-148.
23. Tacke M, Hanke G, Hanke T, Hünig T, (1997) CD28-mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: evidence for functionally distinct forms of CD28. Eur J Immunol 27: 239-247.
24. Dennehy KM, Elias F, Na SY, Fischer KD, Hünig T, et al. (2007) Mitogenic CD28 signals require the exchange factor Vav1 to enhance TCR signaling at the SLP-76-Vav-Itk signalosome. J Immunol 178: 1363-1371.
25. Dennehy KM, Elias F, Zeder-Lutz G, Ding X, Altschuh D, et al. (2006) Cutting edge: monovalency of CD28 maintains the antigen dependence of T cell costimulatory responses. J Immunol 176: 5725-5729.
26. Lahl K, Loddenkemper C, Drouin C, Freyer J, Arnason J, et al. (2007) Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 204: 57-63.
27. Qureshi OS, Zheng Y, Nakamura K, Attridge K, Manzotti C, et al. (2011) Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 332: 600-603.
28. Chen J, Xie L, Toyama S, Hünig T, Takahara S, et al. (2011) The effects of Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody in DSS-induced mice colitis. Int Immunopharmacol 11: 610-617.
29. Siewert C, Menning A, Dudda J, Siegmund K, Lauer U, et al. (2007) Induction of organ-selective CD4+ regulatory T cell homing. Eur J Immunol 37: 978-989.
30. Kang SG, Piniecki RJ, Hogenesch H, Lim HW, Wiebke E, et al. (2007) Identification of a chemokine network that recruits FoxP3(+) regulatory T cells into chronically inflamed intestine. Gastroenterology 132: 966-981.
31. Kleinewietfeld M, Puentes F, Borsellino G, Battistini L, Rotzschke O, et al. (2005) CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset. Blood 105: 2877-2886.
32. Alenzi FQ, (2004) Links between apoptosis, proliferation and the cell cycle. Br J Biomed Sci 61: 99-102.
33. Banz A, Pontoux C, Papiernik M, (2002) Modulation of Fas-dependent apoptosis: a dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells. J Immunol 169: 750-757.
34. Fritzsching B, Oberle N, Pauly E, Geffers R, Buer J, et al. (2006) Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. Blood 108: 3371-3378.
35. Yamaguchi T, Hirota K, Nagahama K, Ohkawa K, Takahashi T, et al. (2007) Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity 27: 145-159.
36. Bailey DP, Kashyap M, Bouton LA, Murray PJ, Ryan JJ, (2006) Interleukin-10 induces apoptosis in developing mast cells and macrophages. J Leukoc Biol 80: 581-589.
37. Wang H, Xu J, Ji X, Yang X, Sun K, et al. (2005) The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus. Cell Immunol 235: 117-121.
38. Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, et al. (2006) Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 355: 1018-1028.
39. Römer PS, Berr S, Avota E, Na SY, Battaglia M, et al. (2011) Preculture of PBMC at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412. Blood.
40. Eastwood D, Findlay L, Poole S, Bird C, Wadhwa M, et al. (2010) Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cells. Br J Pharmacol 161: 512-526.
41. Tincani A, Allegri F, Sanmarco M, Cinquini M, Taglietti M, et al. (2001) Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations-a cooperative project of the European Antiphospholipid Forum. Thromb Haemost 86: 575-583.
42. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M, (2002) Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18 Suppl 1: S96-104.
43. Smyth GK (2005). Limma: linear models for microarray data. In: Gentelman R, Carey V, Dudoit S, Irizarry R, Huber W (Eds) Bioinformatics and Computational Biology Solutions using R and Bioconductor. New York: Springer.
44. Thiede K, Momburg F, Zangemeister U, Schlag P, Schirrmacher V, (1988) Growth and metastasis of human tumors in nude mice following tumor-cell inoculation into a vascularized polyurethane sponge matrix. Int J Cancer 42: 939-945.